The use of or reference to third-party information in this podcast shall not be construed as an endorsement by or affiliation with the third-party information providers or their services.The company’s profit was 59% more than the same period a year ago. Tesla stock rose .Therefore, Stocktwits, Inc., and its affiliates and subsidiaries assume no responsibility or liability for any errors or omissions in the content of the podcast. Tesla (TSLA) reported mixed fourth-quarter results Wednesday, topping earnings estimates while missing on revenue views. Get daily stock ideas from top-performing Wall Street analysts.৩ ঘন্টা আগে. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.įor updates and information on Waterlase iPlus®, Waterlase Express™, and laser dentistry, find BIOLASE online at Facebook at Twitter at Instagram at and LinkedIn at BIOLASE®, Waterlase® and Waterlase iPlus TM are registered trademarks of BIOLASE, Inc.Tsla stockwits Best-in-Class Portfolio Monitoring. BIOLASE has sold over 43,300 laser systems to date in over 80 countries around the world. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's proprietary laser products incorporate approximately 301 patented and 38 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals.
Linkedin stock split pro#
After such sale, Computershare will pay to each holder of record such stockholder's pro rata share of the net proceeds derived from the sale of the fractional interest to which such holder would otherwise be entitled.įor more information on the reverse stock split, please refer to BIOLASE's proxy materials for the Apannual meeting of stockholders, which can be accessed through the investor portion of BIOLASE's website at and on the SEC's EDGAR website, About BIOLASE, Inc.īIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. Rather, Computershare will aggregate all fractional shares and arrange for them to be sold in a timely manner after the effective time of the reverse stock split at the then prevailing prices on the Nasdaq Capital Market. Computershare Trust Company, N.A., the transfer agent for Company common stock, will act as the exchange agent, and can be contacted at (800) 546-5141.īIOLASE will not issue fractional shares that result from the reverse stock split. Record holders of Company common stock will receive a transaction statement with respect to the exchange of such shares for post-reverse split shares.
The Nasdaq Capital Market requires, among other things, that a listing a company's common stock maintain a minimum bid price of at least $1.00 per share.Īt the effective time of the reverse stock split, BIOLASE stockholders will receive one new share of Company common stock for every 25 shares held.
The purpose of the 1-for-25 reverse stock split is to raise the per-share trading price of the Company's common stock to allow for its continuous listing on the Nasdaq Capital Market, among other benefits. There will be no change to the total number of authorized shares of Company common stock as set forth in the Restated Certificate of Incorporation of the Company, as amended. Proportional adjustments will be made to the number of shares of BIOLASE's common stock issuable upon exercise or conversion of BIOLASE's outstanding equity awards and warrants, as well as the applicable exercise price. The 1-for-25 reverse stock split will reduce the number of outstanding shares of Company common stock from approximately 154 million shares to approximately 6.2 million shares.
0 kommentar(er)
